Skip to content
healthcare.dev

Mag 440

NDC 28595-710, Megnesium Oxide, tablet, from Allegis Pharmaceuticals, LLC.

Product NDC
28595-710
Status
Listed
Labeler
Allegis Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/28595-710 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MAGNESIUM OXIDE440 mg/1

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
28595-710-402859507104040 TABLET in 1 BOTTLE (28595-710-40)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 28595-710 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/28595-710 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 28595-710. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.